The Endocrine Society is pleased to announce its Rare Endocrine Disease (RED) Fellows Program, a series designed to equip early-career physicians with the knowledge and practical skills needed to improve outcomes for people living with rare endocrine diseases. The program was developed in partnership with the National Organization for Rare Disorders (NORD) and addresses critical gaps in awareness, diagnosis and care of rare endocrine diseases. The program consists of two core components: The program accepts up...
A new year brings a new therapeutic milestone for weight management: Following its recent U.S. Food and Drug Administration approval, the 25 mg oral semaglutide tablet (brand name: Wegovy), a once-daily pill became available in the United States in early January 2026 for chronic weight management and for reducing the risk of major adverse cardiovascular...
As we leave 2025 behind and look forward to the new year ahead, what better way to kick off 2026 than with a multi-page tribute to the latest class of Endocrine Society Laureate Award winners? In “Meet the 2026 Laureates,” we feature this year’s stellar array of legends of endocrinology from around the world. This...
As this article went to press, Congress has yet to complete a full-year spending bill for the current fiscal year (FY 2026) to fund the National Institutes of Health (NIH). This ongoing uncertainty has impacted NIH’s ability to award grants, with consequences for our member scientists and their work. Meanwhile, the Trump administration aims to release their...
Nicknamed the “butterfly gland” due to its shape, the thyroid’s impact on the body is far reaching. Usually associated with growth and metabolism, recent studies published in The Journal of Clinical Endocrinology & Metabolism – Case Reports show how thyroid dysfunction can impact the heart. The common phrase “heart in my throat” usually refers to...
A woman’s insulin levels in midlife are linked to the timing and duration of menopausal hot flashes, night sweats and cold sweats, according to new research from the University of Victoria (UVic). The study found that having higher insulin levels at age 47 predicted younger onsets of hot flashes and night sweats,” says Faria Athar, lead author...
A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking tirzepatide. The findings, published in The Lancet Obstetrics, Gynaecology, & Women’s Health, could expand treatment possibilities for millions of women struggling with obesity and obesity-related diseases after menopause. Menopause can accelerate age-related weight gain and increase the likelihood of...
People with obesity and high blood pressure may face a higher risk of dementia, according to a new study published in The Journal of Clinical Endocrinology & Metabolism. Dementia is a growing global public health challenge, with no cure currently available. People with dementia experience a severe decline in mental abilities, like memory, thinking and reasoning. The most common forms of dementia are Alzheimer’s disease, vascular dementia and mixed dementia. Dementia is a progressive...
As we leave 2025 behind and look forward to the new year ahead, what better way to kick off 2026 than with a multi-page tribute to the latest class of Endocrine Society Laureate Award winners? In “Meet the 2026 Laureates,” we feature this year’s stellar array of legends of endocrinology from around the world. This...
People with obesity and high blood pressure may face a higher risk of dementia, according to a new study published in The Journal of Clinical Endocrinology & Metabolism. Dementia is a growing global public health challenge, with no cure currently available. People with dementia experience a severe decline in mental abilities, like memory, thinking and reasoning. The most common forms of dementia are Alzheimer’s disease, vascular dementia and mixed dementia. Dementia is a progressive...
